US Pre-Market SEC Filings Roundup — June 15, 2026

15-06-2026

Birkenstock Holding plc announced an offering of €900 million senior notes due 2033 by its subsidiary Birkenstock Group B.V. & Co. KG. Proceeds will be used to redeem €428.5 million of existing 5.25% Senior Notes due 2029, finance share repurchases or refinance debt, and pay fees. The offering is subject to market conditions and there is no assurance of completion.

• · The Notes are expected to be guaranteed on a senior unsecured basis by certain subsidiaries.
• · Application will be made to list the Notes on The International Stock Exchange.
• · Proceeds may also be used for share repurchases or refinancing other indebtedness and general corporate purposes.
• · The information is incorporated by reference into the Company's registration statements on Form F-3 and Form S-8.

15-06-2026

SS Innovations International, Inc. (SSII) furnished a June 2026 Company Presentation, disclosing key operating and financial metrics as of May 31, 2026. The company reported strong year-over-year revenue growth of 106% in Q1 2026 ($11.1M vs $5.1M in Q1 2025) and a cumulative installed base of 210 SSi Mantra systems across 12 countries. However, the revenue growth decelerated sequentially from Q4 2025 ($42.5M vs $11.1M in Q1 2026) and the company remains early-stage with limited scale.

• · Company domiciled in Florida, headquarters in Gurugram, India.
• · Uplisted to Nasdaq in 2025 under ticker SSII.
• · Insider ownership approximately 74% as of June 2, 2026.
• · Board includes Frederic Moll, M.D. (founder of Intuitive Surgical) as Vice-Chairman.
• · Sudhir Srivastava owns 114,468,548 shares (58.8%) and Frederic Moll owns 20,836,298 shares (10.4%).
• · Cumulative installed base grew from 78 systems as of March 31, 2025 to 194 systems as of March 31, 2026 (149% increase).
• · Revenue compounded annual growth rate 2023-2025 was 169%.
• · Full year revenues: 2023 - $5.9M, 2024 - $20.6M, 2025 - $42.5M.
• · No significant safety events reported to date.
• · SSi Mantra currently used across 9 surgical specialties; general surgery (4,869 procedures) and urology (2,686) are the largest categories.
• · 173 pediatric procedures included in total surgeries.

15-06-2026

Li Auto Inc. filed a Form 6-K with the SEC on June 15, 2026, attaching five exhibits: four Next Day Disclosure Returns dated June 8, 10, 11, and 12, 2026, and a Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B. The filing is a procedural regulatory submission and does not contain any financial results, operational metrics, or material business developments.

• · The filing includes Next Day Disclosure Returns for four consecutive days (June 8, 10, 11, 12, 2026).
• · A Monthly Return for Equity Issuer and Hong Kong Depositary Receipts under Chapter 19B is also attached.
• · No financial data, business updates, or material events are disclosed in the filing.

15-06-2026

Prologium Holding Inc. and OPmobility signed a Memorandum of Understanding to jointly develop solid-state battery modules for electric vehicles, starting with performance testing and module development targeting OEM adoption. ProLogium's solid-state battery technology boasts 900 Wh/L volumetric energy density, 380 Wh/kg gravimetric energy density, and fast charging from 5% to 80% in about 6.4 minutes. However, the collaboration is still in early evaluation stages with no definitive agreement, and ProLogium's first overseas gigafactory in Dunkirk, France, is not expected to begin mass production until Q2 2029, indicating a long timeline to commercialization.

• · ProLogium holds over 1,100 global patents (granted and pending).
• · ProLogium's first GWh-class gigafactory in Taoyuan, Taiwan, was inaugurated in 2024 and has shipped more than 800,000 cells to date.
• · The Dunkirk, France gigafactory completed environmental assessment and building permit by end of 2024; construction expected to begin in 2026, with ramp-up between Q4 2028 and Q1 2029, and mass production in Q2 2029.
• · ProLogium received the Edison Awards Gold Award in 2026 for its superfluidized all-inorganic solid-state lithium ceramic battery technology.
• · The business combination with TDAC is subject to a $250 million Minimum Cash condition and other closing conditions.
• · The collaboration with OPmobility is in early evaluation phase with no definitive agreement yet.

15-06-2026

KE Holdings Inc. filed a Form 6-K with the SEC on June 15, 2026, attaching Next Day Disclosure Returns dated June 8-11, 2026. The filing is a routine foreign issuer report and does not contain any financial results, material events, or operational updates.

15-06-2026

SK Telecom reported Q1 2026 consolidated sales of ₩4,392,312 million (down 4.3% from ₩17,940,609 million in FY2024 annualized), with operating profit of ₩537,591 million. Wireless segment sales declined to ₩3,268,788 million (74% of total) from ₩13,318,213 million in FY2024, while fixed-line sales increased to ₩1,049,235 million (24% of total) from ₩4,075,412 million. Total assets decreased to ₩30,021,958 million as of March 31, 2026 from ₩30,515,255 million at end of 2024, and total equity increased to ₩13,347,617 million from ₩11,827,634 million. The company remains compliant with all financial covenants.

• · The company has an unsecured bond (Series 62-3) with principal of ₩90,000 million, issued Aug. 28, 2012, maturing Aug. 28, 2032, with fiscal agent Meritz Securities Co., Ltd.
• · All financial covenants are compliant: debt ratio ≤300%, secured debt ≤100% of share capital, asset disposal ≤₩2 trillion per fiscal year.
• · Compliance certificate submitted on April 13, 2026.
• · Q1 2026 operating profit by segment: Wireless ₩414,888 million, Fixed-line ₩120,700 million, Other ₩2,652 million, with consolidation adjustment of (₩649) million.
• · Finance loss of ₩61,831 million and loss from investments of ₩15,131 million in Q1 2026.
• · R&D costs for Q1 2026 were ₩90,885 million (2.07% of sales), down from ₩392,844 million (2.19%) in FY2024.
• · Retained earnings increased to ₩24,935,298 million as of March 31, 2026 from ₩22,976,127 million at end of 2024.
• · Non-controlling interests decreased to ₩62,766 million from ₩129,007 million.

15-06-2026

ING Groep N.V. filed a Form 6-K with the SEC on June 15, 2026, attaching a press release issued the same day. The filing is a routine foreign issuer report and does not contain any financial results or material business updates.

15-06-2026

Haleon plc reported a share buyback program transaction on June 8, 2026, purchasing 565,285 shares on the London Stock Exchange at a volume-weighted average price of 331.9552 pence per share. No purchases were made on subsequent days (June 9–12, 2026). The buyback is part of the company's ongoing capital return program.

• · Highest price paid per share on June 8: 335.0000 pence
• · Lowest price paid per share on June 8: 330.5000 pence
• · No shares were purchased on June 9, 10, 11, or 12, 2026
• · Buyback executed only on the London Stock Exchange (no activity on CBOE or Aquis)

15-06-2026

Adobe reported Q2 FY2026 revenue of $6.618B, up 12.7% YoY, and net income of $1.712B, up 1.2% YoY. Subscription revenue grew 13.7% to $6.416B, while services and other revenue declined 21.5% to $113M. Operating income rose 6.1% to $2.238B, but gross margin slightly compressed from 89.1% to 89.2%. The company repurchased $2.13B in stock during the quarter and completed an acquisition that added $1.184B to goodwill.

• · Goodwill increased by $1.184B from $12.857B to $14.041B, reflecting an acquisition during the period.
• · Total debt (current + long-term) stood at $6.645B as of May 29, 2026, compared to $6.210B at November 28, 2025.
• · Cash and cash equivalents decreased by $512M to $4.919B from $5.431B at year-end.
• · Stock-based compensation for Q2 was $534M, up from $481M in the prior year quarter.
• · The effective tax rate for Q2 was 23.5% compared to 19.5% in Q2 FY2025.
• · Shares outstanding declined from 413M to 399M due to repurchases.
• · Deferred revenue (current) increased to $7.152B from $6.905B at year-end.

15-06-2026

Toyota Motor Corporation (TMC) filed a 6-K report on June 15, 2026, detailing its ownership stake in Toyota Industries as of March 31, 2026, based on shares outstanding adjusted for treasury shares. The filing also notes that Toyota Industries executed a 1-for-74,100,604 share consolidation on June 3, 2026, which significantly reduced the share count but does not change TMC's economic interest. No financial or operational performance metrics are provided in this filing.

• · Toyota Industries conducted a 1-for-74,100,604 share consolidation on June 3, 2026.
• · The ownership percentage calculation uses 300,468,611 shares (issued shares of 325,840,640 minus treasury shares of 25,372,029).
• · The filing references the Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 (IFRS) announced by Toyota Industries on April 28, 2026.

15-06-2026

Ecopetrol S.A. filed a Form 6-K with the SEC for the month of June 2026, signed by CFO Alfonso Camilo Barco. The filing is a routine foreign private issuer report and contains no financial results, operational updates, or material disclosures.

15-06-2026

VITASPRING BIOMEDICAL CO. LTD. reported no revenue for the three months ended April 30, 2025 and 2024, with a net loss of $80,541 in the current period compared to $216,831 in the prior year period. Total assets decreased to $11,912 from $14,378 as of January 31, 2025, while total liabilities increased to $4,107,653 from $4,029,578. The company's cash balance fell to $0 from $272, and stockholders' deficit widened to ($4,095,741) from ($4,015,200).

• · Selling, general and administrative expenses decreased to $69,147 from $216,831 in the prior year period.
• · Depreciation expense remained unchanged at $2,489 in both periods.
• · Stock-based compensation was $0 in the current period versus $41,217 in the prior year period.
• · Net cash used in operating activities improved to ($787) from ($4,023).
• · Advances from related party for operating expenses were $30,434 in the current period versus $270,613 in the prior year period.
• · Equipment and vehicle, net decreased to $11,617 from $14,106 due to depreciation.
• · Accounts payable and other payables increased to $530,498 from $494,751.
• · Income tax payable increased to $325,116 from $313,722.
• · Advances from related party (liability) increased to $841,039 from $810,105.
• · Accumulated deficit increased to ($5,362,044) from ($5,281,503).

15-06-2026

Pattern Group Inc. filed an S-1 registration statement for a secondary offering of 8,000,000 shares of Series A common stock by a selling stockholder affiliated with a board member. The company will not receive any proceeds from the sale. The stock is listed on Nasdaq under the symbol 'PTRN', with a recent closing price of $20.96 per share as of June 12, 2026. The filing highlights the company's ecommerce acceleration platform, which leverages AI and machine learning across 70+ marketplaces, but also notes that the company is a 'controlled company' and has elected not to comply with certain Nasdaq corporate governance standards.

• · The company was originally incorporated in 2018 as Covalent Group, Inc. in Utah and converted to a Delaware corporation in 2020.
• · Pattern Inc. was originally incorporated in 2013 as iServe Products, Inc. and changed its name to Pattern Inc. in 2019.
• · The selling stockholder is an entity affiliated with a member of the board of directors.
• · The company is a 'controlled company' under Nasdaq rules and has elected not to comply with certain corporate governance standards.
• · The company's technology executes thousands of optimizations daily across tens of thousands of products.
• · The company targets brand partners with a proven track record of selling highly rated products, a loyal customer base, and growth potential, assessed through a proprietary scorecard.
• · Revenue is generated primarily from consumer product sales on global ecommerce marketplaces, with additional revenue from subscription and consulting fees.
• · The company's principal executive offices are located in Lehi, Utah.

15-06-2026

Ascendis Pharma announced Week 182 data from its Phase 3 PaTHway Trial for TransCon PTH in hypoparathyroidism, showing sustained efficacy and safety over 3.5 years. 86% of patients met the composite endpoint, 100% achieved independence from active vitamin D, and eGFR increased by a mean of 11.0 mL/min/1.73 m2 from baseline. The treatment was well-tolerated with no new safety signals.

• · Mean 24-hour urine calcium normalized within 26 weeks and remained normal through Week 182.
• · No patients developed anti-PTH antibodies over 3.5 years.
• · BMD Z-scores corrected from high baseline levels through Week 26 and remained above 0 through Week 182.
• · HPES and SF-36 scores showed sustained improvements in symptoms and quality of life.

15-06-2026

Woodside Energy Group Ltd filed a Form 6-K with the SEC on June 15, 2026, including an ASX announcement responding to media speculation. The filing itself does not provide substantive financial or operational updates beyond confirming the issuance of a market announcement in Australia. No specific financial figures, growth rates, or performance metrics are disclosed in this filing.

• · The filing is a Form 6-K for the month of June 2026, filed under Commission File Number 001-41404.
• · The registrant’s address is Mia Yellagonga, 11 Mount Street, Perth, Western Australia 6000, Australia.
• · The registrant files annual reports under Form 20-F (check mark indicates Form 20-F).
• · The filing includes a single exhibit: ASX Announcement dated June 15, 2026, titled 'Response to media speculation'.
• · The filing was signed by Damien Gare, Corporate Secretary, on June 15, 2026.

15-06-2026

IperionX Ltd filed a Form 6-K with the SEC on June 15, 2026, attaching a press release as Exhibit 99.1. The filing is a routine foreign issuer report and does not contain any financial results or quantitative data.

• · The filing is a Form 6-K submitted under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
• · The press release (Exhibit 99.1) is referenced but its content is not included in the filing text.
• · The registrant's principal executive offices are located at 129 W Trade Street, Suite 1405, Charlotte, North Carolina.

15-06-2026

Lotus Technology Inc. entered into a Convertible Note Purchase Agreement with Geely International (Hong Kong) Limited on June 12, 2026. The agreement provides for a convertible note facility, but the specific principal amount, conversion terms, and interest rate are not disclosed in this summary filing (only the form of note and agreement are filed as exhibits). This represents related-party financing from a major shareholder (Geely) and may provide additional capital but also potential dilution.

• · Convertible Note Purchase Agreement dated June 12, 2026 (three days before filing date)
• · The agreement is between Lotus Technology Inc. and Geely International (Hong Kong) Limited — a related party (Geely is a major shareholder)
• · The filing incorporates the convertible note by reference into three existing registration statements on Form F-3 and Form F-1
• · No monetary amount for the convertible note is disclosed in the main body of this 6-K

15-06-2026

Alterity Therapeutics Ltd filed a Form 6-K with the SEC on June 15, 2026, reporting the cessation of securities (Exhibit 99.1). The filing is a routine foreign issuer report and does not contain financial results or operational updates.

• · The filing incorporates by reference into several existing SEC registration statements (Forms S-8 and F-3).
• · Exhibit 99.1 is a notification of cessation of securities (ATH).

15-06-2026

ZKH Group Limited filed a Form 6-K with the SEC on June 15, 2026, reporting a press release as an exhibit. The filing is a routine foreign issuer report, with no financial results or material events disclosed in the cover page.

• · The filing is a Form 6-K for the month of June 2026.
• · Commission File Number: 001-41885.
• · Principal executive offices are located at 7/F, Tower 4, Libao Plaza, No. 36 Shenbin Road, Minhang District, Shanghai 201106, People's Republic of China.
• · The registrant files annual reports under Form 20-F.
• · The press release (Exhibit 99.1) is referenced but not included in the provided text.

15-06-2026

Artificial Intelligence Technology Solutions Inc. (AITX) filed an 8-K on June 15, 2026, announcing a press release titled 'AITX Positions ROAMEO for Next Growth Phase.' The filing is furnished under Item 8.01 and includes the press release as Exhibit 99.1. No financial figures or period-over-period comparisons were provided in the filing.

• · The press release is titled 'AITX Positions ROAMEO for Next Growth Phase' and is attached as Exhibit 99.1.
• · The filing is furnished, not filed, under the Exchange Act and is not incorporated by reference into any SEC filings.
• · The report was signed by CEO Steven Reinharz on June 15, 2026.

15-06-2026

Strive, Inc. announced on June 15, 2026 that its board of directors maintained the annual dividend rate on its Series A Perpetual Preferred Stock (SATA) at 13.00% and declared daily cash dividends of $0.0493 per share for the period July 1–31, 2026, totaling $1.0846 per share for the full month. The company also stated it has no accumulated or expected current earnings and profits, meaning distributions will generally be treated as tax-deferred return of capital for U.S. investors and exempt from U.S. withholding tax for non-U.S. investors. This filing reflects a stable dividend policy but highlights the company's lack of profitability, as it does not expect to generate earnings in the current year or foreseeable future.

• · The dividend rate of 13.00% is being maintained (not changed) from prior periods.
• · Dividends will be paid daily to stockholders of record as of the close of business on the preceding business day.
• · The company has no accumulated earnings and profits and does not expect to generate current earnings and profits in the current year or the foreseeable future.
• · For U.S. investors, distributions not from earnings/profits will be treated as tax-deferred recovery of capital up to their tax basis.
• · For non-U.S. investors, such distributions are exempt from U.S. dividend withholding tax.

15-06-2026

This filing is a 6-K report from Tower Semiconductor Ltd (TSEM) dated June 15, 2026, which primarily contains contact information for IQE plc's advisors and brokers. No financial results, operational updates, or material corporate events are disclosed.

15-06-2026

Gilat Satellite Networks Ltd., through its subsidiary Wavestream Corporation, has entered into a definitive agreement to acquire Comtech's Satellite & Space Communications segment for $157.5 million, with a $10 million advance payment already made. The acquisition is subject to regulatory approvals including HSR and CFIUS, and customary closing conditions, with a 12-month closing period extendable by three months. The transaction aims to create a leading provider of advanced defense and satellite communications solutions, but carries execution and integration risks typical of large acquisitions.

• · The acquisition is of 100% of the shares of four entities representing Comtech's Satellite & Space Communications segment, excluding Comtech's cyber and services business lines.
• · Closing conditions include HSR waiting period expiration/termination, CFIUS approval, no legal prohibition, accuracy of representations and warranties, and performance of obligations.
• · The Purchase Agreement can be terminated if the acquisition is not consummated within 12 months (extendable by 3 months for regulatory approval).
• · If terminated due to failure to obtain regulatory approvals, the Sellers may not be required to return the $10 million advance payment in certain cases.
• · The filing incorporates the 6-K by reference into multiple registration statements (Form F-3 and several Form S-8s).

15-06-2026

Allot Ltd. announced the resignation of board member Cynthia L. Paul, effective June 15, 2026, due to other business responsibilities. Ms. Paul's departure is not the result of any disagreement with the company or its management. The resignation was disclosed via a Form 6-K filing with the SEC.

• · Ms. Paul's resignation is effective June 15, 2026.
• · The resignation is not due to any disagreement with Allot Ltd. or its management.
• · A press release titled 'Allot Announces Departure of Board Member Cynthia L. Paul' is attached as Exhibit 99.1.
• · The Form 6-K filing incorporates the explanatory note into several of Allot's registration statements (Forms F-3 and S-8).

15-06-2026

Belite Bio, Inc. announced the completion of a rolling submission of a New Drug Application (NDA) to the U.S. FDA for Tinlarebant to treat Stargardt Disease Type 1. This milestone moves the company closer to potential approval for an orphan disease with no currently approved therapies. However, there is no disclosed timeline for FDA acceptance or review, and no financial details on R&D costs or revenue projections were provided in this filing.

• · The NDA is for Stargardt Disease Type 1, a rare genetic eye disease with no currently FDA-approved treatments.
• · The filing is a press release attached as Exhibit 99.1, incorporated by reference into the 6-K.
• · No specific financial figures, clinical trial results, or timelines for FDA action were provided in the filing.

15-06-2026

Eureka Acquisition Corp filed Amendment No. 1 to its S-4 registration statement in connection with its proposed business combination with Marine Thinking Inc. The filing details shareholder voting procedures, redemption rights, and the timeline for the extraordinary general meeting (EGM). If the business combination is not approved by July 3, 2026, the SPAC will dissolve and liquidate the trust account. Public shareholders may redeem their shares for cash regardless of how they vote, but redemptions could significantly dilute the ownership of non-redeeming shareholders.

• · The SPAC must complete an initial business combination by July 3, 2026, or dissolve and liquidate the trust account.
• · Public shareholders can redeem shares for cash even if they vote 'FOR' the business combination.
• · Redemption requests must be submitted by 5:00 p.m. Eastern time, two business days before the EGM.
• · If 1,465,117 shares (50% of maximum redemption) are redeemed, pro forma net tangible book value per share would be affected.
• · The Sponsor and SPAC directors/officers have agreed to vote their shares in favor of the business combination; they own approximately [●]% of outstanding shares.
• · Shareholders holding more than 15% of Public Shares (acting as a group) cannot redeem shares in excess of that threshold.

15-06-2026

Ocean Capital Acquisition Corporation, a blank check company, announced the pricing of its $100 million initial public offering of 10,000,000 units at $10.00 per unit. Each unit consists of one ordinary share, one redeemable warrant (exercisable at $11.50 per share), and one right to receive an ordinary share upon a business combination. The IPO is expected to close on June 10, 2026, and the units will trade on the NYSE under the ticker 'OCACU'.

• · The Company is a blank check company incorporated in the British Virgin Islands, with no specific industry target for a business combination.
• · The registration statement on Form S-1 (File No. 333-282462) was declared effective on June 8, 2026.
• · The underwriter has a 45-day option to purchase up to an additional 1,500,000 units to cover over-allotments.
• · The units are expected to begin trading on the NYSE on June 9, 2026, and the IPO is expected to close on June 10, 2026.

15-06-2026

Janus Henderson is soliciting shareholder votes for a special meeting on June 29, 2026, to approve a new investment advisory agreement following its agreement to become a privately-owned company. The Board of Trustees unanimously recommends voting 'FOR' the proposal, and the company emphasizes that the change of ownership will not alter the team, strategy, fee rate, or focus. However, the filing reveals that more than 50% of votes are still needed for approval, and multiple rounds of urgent outreach indicate that a significant portion of shareholders have not yet voted.

• · The definitive proxy statement was filed with the SEC on March 2, 2026.
• · Shareholders can vote by calling a live proxy specialist at 1-855-206-2338 (Mon–Fri 9 a.m.–10 p.m. ET; Sat–Sun 10 a.m.–8 p.m. ET) or online via instructions on the proxy ballot.
• · A video message from CEO Ali Dibadj is available at https://bcove.video/4fKgOsf.
• · The filing includes multiple rounds of text message templates for the day of the meeting, indicating an aggressive get-out-the-vote effort.
• · The solicitation is being conducted under SEC Rule 14a-12.

15-06-2026

Alternus Clean Energy, Inc. (ALCE) filed its 10-K annual report, highlighting a capital-light, Energy-as-a-Service (EaaS) model with over 70% of EverOn's near-term growth already in a blue-chip pipeline, providing clear revenue visibility. However, the company faces material risks including substantial indebtedness that could reduce cash flow available for operations and growth, potential negative impacts from U.S. tariffs on critical minerals used in solar manufacturing, and the risk that reductions in clean energy incentives could diminish market demand and financing availability.

• · The company's capital-light model delivers energy under long-term service contracts, removing upfront capital expenditure for customers while retaining ownership of income-generating assets.
• · A delay between making significant upfront investments in renewable energy projects and receiving revenue could materially and adversely affect liquidity, business, and results of operations.
• · Substantial indebtedness requires dedicating a substantial portion of cash flow to debt repayment, reducing availability for working capital, capital expenditures, acquisitions, or joint ventures.
• · Potential U.S. tariffs on processed critical minerals (including tellurium) under Section 232 could negatively impact demand, price levels, net sales, or increase costs for solar modules.
• · Limitations on tax incentives (Section 45X, ITC, PTC) could reduce economic returns for manufacturers and investors, reducing financing availability and demand for solar and wind components.

15-06-2026

Janus Detroit Street Trust filed a DEFA14A soliciting shareholder votes to approve a new investment advisory agreement following Janus Henderson's agreement to become a privately-owned company. The Board of Trustees unanimously recommends a 'FOR' vote, and the special meeting has been adjourned to June 29, 2026, to allow additional time for voting. While over 92% of votes received are in favor, the proposal still requires 50% shareholder approval, and outreach continues to encourage participation.

• · The definitive proxy statement was filed with the SEC on March 2, 2026.
• · The special meeting is scheduled for June 29, 2026.
• · Shareholders can vote by phone at 1-855-206-2309 or online via a provided link.
• · A video message from CEO Ali Dibadj is available at https://bcove.video/4fKgOsf.
• · The new advisory agreement will have substantially identical terms with no change to advisory fees or investment management services.
• · The filing includes multiple templates for text messages and letters to encourage voting, including day-of-meeting reminders.

15-06-2026

Greenbriar Sustainable Living Inc. filed a Form 6-K with the SEC on June 15, 2026, attaching a news release dated June 12, 2026. The filing was signed by CEO Jeff Ciachurski and indicates the company files annual reports under Form 20-F. No financial figures or performance metrics were disclosed in the filing.

• · The filing is a Form 6-K for the month of June 2026.
• · Commission File No. is 000-56391.
• · The company's address is 632 Foster Avenue, Coquitlam, British Columbia, Canada V3J 2L7.
• · The company files annual reports under Form 20-F, not Form 40-F.

15-06-2026

XCF Global, Inc. filed an S-4 registration statement for a proposed three-party merger with DevvStream and Southern Energy Renewables, creating an integrated platform focused on sustainable aviation fuel and carbon credits. The company has discontinued its digital asset treasury strategy after a settlement with Helena, and faces Nasdaq non-compliance with a hearing pending. DevvStream has incurred recurring losses and substantial doubt exists about its ability to continue as a going concern.

• · DevvStream has only 2 full-time employees and 5 independent contractors.
• · The company received a Nasdaq delisting notice on November 18, 2025, and a hearing was held on May 19, 2026; decision pending.
• · The equity line of credit with Helena was terminated effective June 3, 2026.
• · DevvStream is a reporting issuer in British Columbia, Alberta, and Ontario, subject to MI 61-101.
• · The company concluded no collateral benefit exists, so minority approval and formal valuation are not required for the merger.

15-06-2026

CH4 Natural Solutions Corp filed its 10-Q for the quarter ended March 31, 2026, reporting a net loss of $100,452, slightly higher than the $98,509 loss in the same quarter last year. The company has no revenue, minimal assets ($1.1M), and a shareholders' deficit of $372,191. Cash balance remains zero, and the company relies on related-party funding and deferred offering costs.

• · General and administrative expenses increased slightly from $98,509 in Q1 2025 to $100,452 in Q1 2026.
• · Deferred offering costs increased from $1,018,517 at Dec 31, 2025 to $1,073,606 at Mar 31, 2026.
• · Accounts payable increased from $0 at Dec 31, 2025 to $12,490 at Mar 31, 2026.
• · Accrued expenses increased from $512,925 at Dec 31, 2025 to $568,014 at Mar 31, 2026.
• · Due to related party increased from $509,158 at Dec 31, 2025 to $597,120 at Mar 31, 2026.
• · Weighted average shares outstanding remained constant at 6,666,667 for both periods.
• · Basic and diluted net loss per share was $(0.02) in Q1 2026 vs $(0.01) in Q1 2025.
• · Cash balance remained zero throughout both periods.
• · Noncash investing and financing activities: deferred offering costs included in accrued expenses were $55,089 in Q1 2026 vs $255,693 in Q1 2025.

15-06-2026

Grupo Aval Acciones y Valores S.A. announced on June 12, 2026, that it made a scheduled interest payment on its Eighth Issuance of Notes (denominated in Colombian Pesos) in accordance with the terms of the offering memorandum. This is a routine debt service obligation and does not indicate any change in the company's financial condition or operations.

• · The interest payment was made on the Eighth Issuance of Notes, which were issued in Colombian Pesos in the local market.
• · The payment was made on June 12, 2026, and the filing was submitted to the SEC on June 15, 2026.

15-06-2026

Ucommune International Ltd (NASDAQ: UK) closed a securities exchange on June 11, 2026, issuing 1,330 Series B Convertible Preferred Shares in exchange for an equal number of Series A Convertible Preferred Shares held by an investor. The exchange involved the cancellation of the Series A shares and the adoption of a new Certificate of Designations for the Series B shares, which carry substantially similar terms. This transaction appears to be a restructuring of existing preferred equity, with no new capital raised and no material change in the company's financial position.

• · The Series B Preferred Shares have a par value of $0.24 each and a Fixed Conversion Price of $2.59 per Class A Ordinary Share.
• · The conversion rate for Series B Preferred Shares is 125% of the Conversion Base Amount divided by the Conversion Price.
• · Dividends on Series B Preferred Shares accrue at the Dividend Rate and are payable semi-annually, with the first Dividend Date on July 1, 2026.
• · The beneficial ownership conversion limitation is set at 4.99% of outstanding Class A Ordinary Shares, which can be increased to up to 9.99% with 61 days' notice.
• · The exchange agreement includes customary representations, warranties, and indemnification obligations by the company.

15-06-2026

Greenwave Technology Solutions, Inc. (GWAV) filed its 10-K annual report for the year ended December 31, 2025, reporting a 40.1% increase in revenue to $46.66 million, driven by strong operational growth. However, gross profit declined 8.6% to $11.87 million, and the company reported a net loss available to common stockholders of $24.60 million, though this was a significant improvement from the $100.45 million loss in 2024. The company continues to face going concern risks and material weaknesses in internal controls.

• · Cash decreased 63.7% from $2.58 million to $0.94 million.
• · Total assets decreased 12.5% from $63.09 million to $55.17 million.
• · Total liabilities increased 11.9% from $26.13 million to $29.23 million.
• · Accumulated deficit grew to $520.91 million from $496.31 million.
• · Basic net loss per share improved from $(932.14) to $(41.25).
• · The company's independent registered public accounting firm expressed going concern doubts.
• · Material weaknesses in internal control over financial reporting were noted.
• · Revenue growth was driven by a 40.1% increase, but gross margin contracted significantly.

15-06-2026

Bio Key International's total revenue declined 14% YoY to $5,937,555 in 2025, driven by a 34% drop in license fees to $3,423,300. However, hardware revenue surged 112% to $1,342,148, increasing its share of revenue from 9% to 22%. The net loss widened to -120% of revenue from -62% in 2024, reflecting higher operating expenses and an impairment of investment.

• · Hardware revenue share grew from 9% in 2024 to 22% in 2025, while license fees share fell from 75% to 58%.
• · Cost of hardware increased 130% YoY to $1,189,464, outpacing hardware revenue growth.
• · Hardware reserves (negative cost) increased 141% to $(513,400), indicating inventory write-downs or allowances.
• · Operating loss as a percentage of revenue worsened from -58% to -115%.
• · Total operating expenses rose from 139% of revenue to 192%, driven by a 42% impairment of investment.
• · Loan transaction costs increased 52% to $256,833.
• · Net cash flows from non-cash expenses were approximately $3,568,000 positive, but changes in working capital consumed approximately $984,000.
• · The company faces international risks including longer payment cycles, collection difficulties, and FCPA compliance.

15-06-2026

TechCreate Group Ltd. filed a Form 6-K on June 15, 2026, furnishing a press release dated June 12, 2026, in which the company responds to NYSE American's commencement of delisting proceedings. The filing indicates the company is facing potential delisting from the NYSE American exchange, which is a material negative event for shareholders.

• · The filing is a Form 6-K for the month of June 2026.
• · Commission File Number: 001-42865.
• · The company's address is 336 Smith Street, #06-303, New Bridge Centre Singapore 050336.
• · The press release is dated June 12, 2026.
• · The company states it is not furnishing the information under Rule 12g3-2(b).

15-06-2026

AMASS Brands Inc. entered into Amendment No. 2 to its warrant with Streeterville Capital, LLC on June 12, 2026, reducing the exercise price to $3.00 per share for a 90-day period (the Reduced Exercise Price Period), after which the price reverts to $16.00 per share. The company may terminate the reduced price period upon two trading days' notice. This amendment modifies the warrant originally issued under a Securities Purchase Agreement dated March 17, 2026, and previously amended on April 7, 2026 and May 29, 2026.

• · The warrant was originally issued in connection with a Securities Purchase Agreement dated March 17, 2026, and was previously amended on April 7, 2026 and May 29, 2026.
• · The company may terminate the Reduced Exercise Price Period at any time upon two trading days' prior written notice.
• · All other terms and conditions of the Warrant remain unchanged and in full force and effect.

15-06-2026

Decoy Therapeutics Inc. (formerly Salarius Pharmaceuticals, Inc.) filed an S-1 registration statement for the resale of up to 808,000 shares of common stock by C/M Capital Master Fund, LP, the selling stockholder under an equity line of credit (ELOC) established in December 2024. The company may receive up to $5,000,000 in gross proceeds from the sale of Purchase Shares to the selling stockholder, with 50% of net proceeds required to redeem outstanding Series B Non-Voting Convertible Preferred Stock and the remainder for working capital. The company is a pre-clinical stage biotechnology firm with no approved products or product revenue, and its stock is listed on Nasdaq under the symbol DCOY.

• · The company effected a 1-for-15 reverse stock split in August 2025 and a 1-for-12 reverse stock split in March 2026.
• · The Merger with Legacy Decoy closed on January 8, 2026; the company changed its name from Salarius Pharmaceuticals, Inc. to Decoy Therapeutics Inc.
• · The company has no products approved for commercial sales and has not generated any revenue from product sales.
• · The selling stockholder is considered an 'underwriter' under the Securities Act.
• · The registration statement is subject to completion and not yet effective.

15-06-2026

Landesbank Baden-Wuerttemberg filed its quarterly 13F-HR report for the period ending March 31, 2026, disclosing holdings in seven equity securities with a total reported value of approximately $489.8 million. The portfolio is concentrated in international equities, with the largest positions in Alibaba Group (ADS) at $221.0 million and Ferrovial SE at $206.1 million, together representing about 87% of total holdings.

• · All seven positions are held with sole voting and dispositive power; no shared or no-ownership positions reported.
• · The filing was signed by Anke Pross, Group Leader of Regulation Capital Markets, on June 11, 2026.
• · The portfolio is heavily weighted toward Chinese ADRs (Alibaba and JD.com) and Spanish infrastructure (Ferrovial), with minimal exposure to European banks and automotive sectors.

15-06-2026

ERock, Inc. filed an 8-K on June 15, 2026, announcing the adoption of an Amended and Restated Certificate of Incorporation that establishes a three-class capital structure: 800M shares of Class A Common Stock, 350M shares of Class B Common Stock, and 20M shares of Preferred Stock. The filing details the exchange mechanism whereby Class B Units of Enchanted Rock Holdings, LLC can be surrendered along with Class B Common Stock for Class A Common Stock, and includes protective provisions for Class B stockholders. No financial results or performance metrics were disclosed.

• · The original certificate of incorporation was filed on January 20, 2026 under the name 'Enchanted Rock, Inc.' and amended on March 16, 2026 to change the name to 'ERock, Inc.'
• · Class A Common Stock carries one vote per share and dividend rights; Class B Common Stock carries one vote per share but no dividend or liquidation rights.
• · Class B Common Stock is non-redeemable and automatically retired upon exchange of corresponding Class B Units.
• · The Corporation must maintain a one-to-one ratio between Class A Units owned by ER Holdings and outstanding Class A Common Stock (excluding certain shares).
• · Protective provisions require a separate class vote of Class B Common Stock holders to amend Sections 4.7 through 4.12 of the Certificate of Incorporation.

15-06-2026

Digital Brands Group, Inc. (DBGI) filed an 8-K on June 15, 2026, reporting entry into a material agreement (Exhibit 10.1) under Items 1.01, 2.03, 3.02, and 9.01. The filing indicates a significant contractual event, likely involving debt or financing, but no specific financial figures or performance metrics are disclosed in the provided content.

• · Filing includes Exhibit 10.1, which is the material agreement.
• · Items reported: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 9.01 (Financial Statements and Exhibits).

15-06-2026

Silvercorp Metals Inc. announced a 50% increase in mineral reserve tonnes and a 20% increase in silver ounces for its Ying Mining District, as reported in a June 12, 2026 news release filed with the SEC on Form 6-K. The filing does not provide any financial results or period-over-period comparisons, so no negative or flat metrics are available to report.

• · The filing is a Form 6-K for the month of June 2026, with Commission File No. 001-34184.
• · The news release is dated June 12, 2026, and is included as Exhibit 99.1.
• · The company's principal executive office is in Vancouver, BC, Canada.

15-06-2026

DRC Medicine Inc. filed Amendment No. 3 to its S-4 registration statement for a business combination with Ribbon Acquisition Corp, a SPAC. The transaction involves a share exchange, domestication of Ribbon from Cayman Islands to Delaware, and a merger where Ribbon will merge into a subsidiary of DRC Medicine Inc. The combined entity will issue up to 40,803,846 shares of common stock. However, the filing is preliminary and subject to completion, with no definitive ownership percentages or pricing disclosed yet.

• · The filing is Amendment No. 3 to Form S-4, filed on June 12, 2026, with a filing date of June 15, 2026.
• · The Business Combination Agreement was entered into on June 30, 2025.
• · The Share Exchange was implemented on March 1, 2026, with Intermediate Holdco and DRC.
• · A Joinder Agreement was entered into on June 3, 2026, to add Intermediate Holdco as a party.
• · The Domestication is intended to occur one business day prior to the Closing Date.
• · Ribbon's securities trade on Nasdaq under symbols RIBBU, RIBB, and RIBBR.
• · The Sponsor may receive up to $1,500,000 in working capital loans convertible into units at $10.00 per unit.
• · No definitive ownership percentages for Pubco are provided in the filing (marked as [ ]).

15-06-2026

AST SpaceMobile held its 2026 Annual Meeting on June 12, 2026, with 87.7% of total voting power represented (253.5 million shares). Stockholders re-elected all 10 director nominees, ratified KPMG LLP as auditor for the fiscal year ending December 31, 2026, and approved, in a non-binding vote, the compensation of named executive officers. All proposals passed with strong support, though Proposal 3 (say-on-pay) received 17.6 million votes against, representing about 2.0% of votes cast (excluding broker non-votes).

• · Class C common stock carries 10 votes per share, while Class A and Class B carry 1 vote per share.
• · Record date for voting was April 22, 2026.
• · Broker non-votes totaled 80,999,070 on director elections and say-on-pay; no broker non-votes on auditor ratification.
• · Highest vote for among directors: Ronald Rubin (873,653,887 votes for; 2,314,855 withheld).
• · Lowest vote for among directors: Richard Sarnoff (855,702,211 votes for; 20,266,531 withheld).
• · Inspector of Election certified the voting results.

15-06-2026

Leader's Advantage Acquisition Corp., a Cayman Islands blank check company, filed an S-1 registration statement on June 12, 2026, to raise up to $150,000,000 through an initial public offering of 15,000,000 units at $10.00 per unit, each consisting of one Class A ordinary share and one-half of one redeemable warrant. The company has not selected any business combination target and intends to use the proceeds to effect a merger or acquisition. While the IPO provides substantial capital, the sponsor's shares acquired for a nominal price ($25,000 for 4,312,500 Class B shares) will cause immediate and substantial dilution for public shareholders, and the company's blank check structure carries inherent risks including no identified target and potential redemption limitations.

• · The offering is subject to SEC effectiveness; no sales may occur until the registration statement is declared effective.
• · The warrants become exercisable 30 days after completion of an initial business combination and expire five years thereafter.
• · The trust account proceeds will not be used to pay excise taxes under the Inflation Reduction Act of 2022.
• · Public shareholders may redeem their shares in connection with a business combination, but are limited to 15% aggregate redemption without prior consent if a shareholder vote is used.
• · The sponsor's founder shares (4,312,500 Class B shares) were purchased at approximately $0.0058 per share, resulting in immediate and substantial dilution to public shareholders upon IPO closing.
• · The underwriter is purchasing 100,000 Class B ordinary shares at $10.00 per share in a private placement closing simultaneously with the IPO.
• · The company may enter into non-redemption or forward-purchase agreements with certain investors, potentially allowing a business combination to close even if a majority of public shareholders oppose it.
• · No business combination target has been identified, and no substantive discussions have been initiated as of the filing date.